𝔖 Bobbio Scriptorium
✦   LIBER   ✦

Anti-PCSK9 Monotherapy for Hypercholesterolemia

✍ Scribed by Koren, Michael J.; Lundqvist, Pernille; Bolognese, Michael; Neutel, Joel M.; Monsalvo, Maria Laura; Yang, Jingyuan; Kim, Jae B.; Scott, Rob; Wasserman, Scott M.; Bays, Harold

Book ID
122552567
Publisher
Elsevier Science
Year
2014
Tongue
English
Weight
189 KB
Volume
63
Category
Article
ISSN
1558-3597

No coin nor oath required. For personal study only.

πŸ“œ SIMILAR VOLUMES

134 PCSK9 IN FAMILIAL HYPERCHOLESTEROLEM
134 PCSK9 IN FAMILIAL HYPERCHOLESTEROLEMIA (FH)
✍ Lambert, G.; Rye, K.-A.; Burnett, J.; Barter, P.; Marais, D. πŸ“‚ Article πŸ“… 2011 πŸ› Elsevier Science 🌐 English βš– 39 KB
Mutations in PCSK9 cause autosomal domin
Mutations in PCSK9 cause autosomal dominant hypercholesterolemia
✍ Abifadel, Marianne; Varret, Mathilde; RabΓ¨s, Jean-Pierre; Allard, Delphine; Ougu πŸ“‚ Article πŸ“… 2003 πŸ› Nature Publishing Group 🌐 English βš– 133 KB

Autosomal dominant hypercholesterolemia (ADH; OMIM144400), a risk factor for coronary heart disease, is characterized by an increase in low-density lipoprotein cholesterol levels that is associated with mutations in the genes LDLR (encoding low-density lipoprotein receptor) or APOB (encoding apolipo